6-K

PROXY STATEMENT

Company: NYMOX PHARMACEUTICAL CORP
Filed: April 20, 2009
Period of Report: April 20, 2009
Accession Number: 0001176256-09-000379

View Document ↗ View on SEC.gov ↗